Pro-apoptotic effect of anti-beta(1)-adrenergic receptor antibodies in periodontitis patients

REINA S, GANZINELLI S, STERIN-BORDA L, BORDA E.

INTERNATIONAL IMMUNOPHARMACOLOGY

ELSEVIER SCIENCE BV

Lugar: Amsterdam; Año: 2012 vol. 14 p. 710 - 721

1567-5769

An anti-beta(1)-adrenergic antibody from the sera of periodontitis patients (anti-beta(1)-AR IgG) against the second extracellular loop of the human â(1)-adrenoceptor (beta(1)-AR) has been shown to cause rat atria apoptosis. The anti-â(1)-AR IgG binds and activates atria beta(1)-AR, increasing the intracellular calcium concentration, which, in turn, activates caspases-3, -8, and -9. The beta(1)-AR and the post-receptor activation of calcium/calmodulin (CaM) lead to increased inducible nitric oxide synthase (iNOS) activity, with an increase in cyclic GMP (cGMP) accumulation as well as increased JNK phosphorylation and cyclic AMP (cAMP) production. We also observed an apoptotic effect of anti-beta(1)-AR IgG, with increased generation of PGE(2). Comparatively, xamoterol, an authentic â(1)-AR agonist, mimicked the autoantibody effect on rat atria beta(1)-AR apoptosis. Our results suggest that autoantibodies from the sera of periodontitis patients bind and interact with rat atria beta(1)-AR, provoking apoptosis. This implicates a series of modulatory cardiac signaling events that could alter normal heart function and may occur with chronic stimulation of the atria beta(1)-AR, which could lead to heart failure. These results suggest an important link between periodontitis and cardiovascular disease.